Article examines reasons contributing to epidemic of lung cancer in U.S. women

April 13, 2004

An article in the April 14 issue of The Journal of the American Medical Association (JAMA) reviews current information on the "epidemic" of lung cancer in U.S. women, and explores contributing factors and possible reasons for increased lung cancer deaths in women.

Jyoti D. Patel, M.D., of the Feinberg School of Medicine, Northwestern University, Chicago, and colleagues write that the death rate from lung cancer in U.S. women rose 600 percent from 1930 to 1997, surpassing breast cancer as the leading cause of cancer death by nearly 20,000 patients a year. The authors cite data that indicate "an estimated 80,100 U.S. women were diagnosed as having lung cancer in 2003 and 68,800 died from their disease."

However, the authors point out that women are targeted in tobacco advertising, and teenage girls are often drawn to cigarette smoking under a variety of social pressures, and also that "smoking remains the primary cause of lung cancer, and nearly one-quarter of women in the United States continue to smoke. Whether women are more susceptible to the carcinogenic effects of tobacco smoke than men is debatable. What is not debatable, however, is that important differences exist among men and women with lung cancer. Women smokers are more likely than men to develop adenocarcinoma of the lung. Women who have never smoked are more likely to develop lung cancer than men who have never smoked. Mounting evidence suggests that this could be due, in part, to estrogen signaling."

The authors add that in the past, major studies for lung cancer prevention and early diagnosis have excluded women. "... it is critical that future lung cancer research specifically include a proportion of women that reflects the true incidence of lung cancer in women."

According to the authors, one of the most important challenges lies in avoiding the U.S. scenario in other parts of the world.

"Sociocultural constraints that previously discouraged tobacco use by women continue to weaken in many developing countries. Smoking prevalence among women continues to increase in these countries, often accelerated by aggressive advertising campaigns targeted directly to women. The extraordinary increase in lung cancer rates seen among U.S. women in the 20th century will be repeated among women in developing countries during this century unless effective tobacco control measures are implemented. Curtailing the increase in tobacco use among women in developing countries represents one of the greatest opportunities for disease prevention in the world today," the authors conclude.
-end-
(JAMA. 2004;291:1763-1768. Available post-embargo at JAMA.com)

The JAMA Network Journals

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.